Corrects serum calcium for low albumin levels to assess true calcium status

Calculates net fluid balance for volume status assessment and fluid management in hospitalized patients

Rapid assessment of hemodynamic status

Estimates 10-year probability of major osteoporotic and hip fractures

Guides workup of incidentally discovered adrenal masses based on size and imaging characteristics

Calculates BMI percentile for children and adolescents (2-20 years) using CDC growth charts

Assessment of newborn condition at 1 and 5 minutes after birth

Assess functional status and prognosis in cancer patients

Assess functional impairment in cancer patients (0-100 scale)

Determine cancer stage based on TNM classification

Calculate chemotherapy dose based on body surface area

Risk stratification for complications in febrile neutropenia

Grade prostate cancer based on histologic patterns

Estimate 5-year and lifetime breast cancer risk

Interpret Oncotype DX score for breast cancer treatment decisions

Stage non-small cell lung cancer using TNM 8th edition

Stratify colorectal cancer risk and screening recommendations

Barcelona Clinic Liver Cancer (BCLC) staging system — the internationally accepted standard for HCC treatment allocation

International Prognostic Index for Non-Hodgkin Lymphoma — validated for DLBCL and widely applied across aggressive lymphomas

International Metastatic RCC Database Consortium (Heng criteria) — risk stratification and first-line therapy selection for metastatic renal cell carcinoma

Risk of Ovarian Malignancy Algorithm — combines CA-125 and HE4 to stratify ovarian cancer risk before surgery

Calculate PSA velocity and doubling time to guide prostate cancer surveillance and treatment decisions

International Staging System and Revised ISS — prognosis and treatment intensity guidance for multiple myeloma

FIGO 2023 staging system for endometrial/uterine cancer — revised staging with molecular classification integration

MSI/MMR-based treatment algorithm for colorectal cancer — guides immunotherapy eligibility, adjuvant chemotherapy decisions, and Lynch syndrome screening